Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

Journal of Clinical Investigation

Volumn 103, Issue 11, 1999, Pages 1509-1515

  Geraci, Mark W ^a,c   Gao, Bifeng ^a   Shepherd, David C ^a   Moore, Mark D ^a   Westcott, Jay Y ^b   Fagan, Karen A ^a,b   Alger, Lori A ^a   Tuder, Rubin M ^a,b,c   Voelkel, Norbert F ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Pulmonary Hypertension Center   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN F1 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE HYPERTROPHY; HYPOXIA; LUNG BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0032729325     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5911     Document Type: Article

References (31)

1. Bunting, S., Gryglewski, R., Moncada, S., and Vane, J.R. 1976. Arterial walls generate from prosraglandin endoperoxidases a substance (prostaglandin X) which relaxes strips of mesemeric and coeliac arteries and inhibits platelet aggregation. Prostaglandins. 12:897-913.
2. Shaul, P.W., Kinanae, B., Farrar, M.A., Buja, M., and Magness, R.R. 1991. Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery: alteration after prolonged hypoxia in the rat. J. Clin. Invest. 88:447-455.
3. 2, and prostacyclin. Pharmacol. Rev. 30:293-331.
4. Libby, P., Warner, S.J.C., and Friedman, G.B. 1988. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prosranoids. J. Clin. Invest. 81:487-498.
5. Owen, N.E. 1985. Prostacyclin can inhibit DNA synthesis in vascular smooth muscle cells. In Prostaglandins, leukotrienes, and lipoxins. J.M. Bailey, editor. Plenum Press. New York, NY. 193-204.
6. Jugdutt, B.F., Hutchins, G.M., Bulkley, B.H., and Becker, L.C. 1979. Infarct size reduction by prostacyclin after coronary artery occlusion in conscious dogs. Clin. Res. 27:177A. (Abstr.)
7. Ribeiro, L.G.T., et al. 1981. Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality. Am. J. Cardiol. 47:835-840.
8. Pereira, B., Wu, K.K., and Wang, L.H. 1993. Bovine prostacyclin synthase: purification and isolation of partial cDNA. Biochem. Biophys. Res. Commun. 197:1041-1048.
9. Hara, S., et al. 1994. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J. Biol. Chem. 269:19897-19903.
10. Pereira, B., Wu, K.K., and Wang, L.H. 1994. Molecular cloning and characterization of bovine prostacyclin synthase. Biochem. Biophys. Res. Commun. 203:59-66.
11. Miyata, A., et al. 1994. Molecular cloning and expression of human prosracyclin synthase. Biochem. Biophys. Res. Commun. 200:1728-1734.
12. Hara, S., et al. 1995 Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 216:862-867.
13. Rubin, L.J. 1995. Pathology and pathophysiology of primary pulmonary hypertension. Am. J. Cardiol. 75:51A-54A.
14. Christman, B.W., et al. 1992. An imbalance between excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327:70-75.
15. Badesch, D.B., et al. 1989. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 1:489-498.
16. Rabinovitch, M., et al. 1988. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat. Am. J. Phvsiol. 254:H500-H508.
17. Tuder, R.M., et al. 1999. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. J. Respir. Crit. Care Med. 159:1925-1932.
18. Barst, R.J., et al. 1994. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann. Intern. Med. 121:409-415.
19. Barst, R.J., et al. 1996. A comparison of continuous intravenous epoprosrenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-301.
20. Walmrath, D., et al. 1995. Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am. J. Respir. Crit. Care Med. 151:724-730.
21. Walmrath, D., et al. 1996. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:991-996.
22. Zobel, G., Dacar, D., Rodl, S., and Friehs, I. 1995. Inhaled nitric oxide versus inhaled prosracyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr. Res. 38:198-204.
23. Glasser, S.W., et al. 1988. Two SP-C genes encoding human pulmonary surfactant proteolipid. J. Biol. Chem. 263:10326-10331.
24. Korfhagen, T.R., et al. 1990. Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA. 87:6122-6126.
25. Kaur, S., et al. 1989. Targeted ablation of alpha-crystallin-synthesizing cells produces lens-deficient eyes in transgenic mice. Development. 105:613-619.
26. Halbower, A.C., Mason, R.J., Abman, S.H., and Tuder, R.M. 1994. Agarose infiltration improves morphology of cryostat sections of lung. Lab. Invest. 71:149-153.
27. Voelkel, N.F., et al. 1996. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J. Clin. Invest. 97:2491-2498.
28. Wesrcott, J.Y., et al. 1986. Analysis of 6-keto PGF 1α. 5-HETE and LTC4 in rat lung: comparison of GC/MS, RIA, and EIA. Prostaglandins. 32:857-873.
29. Fagan, K.A., et al. 1999. The pulmonary circulation of mice with either homozygous or heterozygous disruption of endothelial nitric oxide synthase is hyperresponsive to chronic mild hypoxia. J. Clin. Invest. In press.
30. Ivy, D.D., et al. 1997. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J. Clin. Invest. 99:1179-1186.
31. Chida, M., and Voelkel, N.F. 1996. Effects of acute and chronic hypoxia on rat lung cyclooxygenase. Am. J. Physiol. 270:L872-L878.